• GSK plc GSK.N, GSK is expected to show a rise in quarterly revenue when it reports results on October 29 for the period ending September 30 2025

• The Brentford Middlesex-based company is expected to report a 6.0% increase in revenue to $11.043 billion from $10.41 billion a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for GSK plc is for earnings of $1.26 per share.

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy," 5 "hold" and 2 "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for GSK plc is $41.00, about 5.5% below its last closing price of $43.24

This summary was machine generated October 27 at 11:06 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)